Catastrophic multiple organ ischemia due to an anti-Pr cold agglutinin developing in a patient with mixed cryoglobulinemia after treatment with rituximab

American Journal of Hematology

Volumn 84, Issue 2, 2009, Pages 120-122

  Ruch, Joshua ^a   McMahon, Brandon ^a   Ramsey, Glenn ^a   Kwaan, Hau C ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALBUMIN; ANTIBODY; COLD AGGLUTININ; CREATININE; FRESH FROZEN PLASMA; HEMOGLOBIN; IMMUNOGLOBULIN HEAVY CHAIN; IMMUNOGLOBULIN KAPPA CHAIN; IMMUNOGLOBULIN LAMBDA CHAIN; LACTIC ACID; METHOTREXATE; PR ANTIBODY; PREDNISONE; RITUXIMAB; UNCLASSIFIED DRUG;

ABDOMINAL PAIN; ADULT; ANTIBODY DETECTION; ANTIBODY TITER; ARM WEAKNESS; ARTICLE; AUTOIMMUNE HEMOLYTIC ANEMIA; BLOOD CELL COUNT; BLOOD PH; BONE MARROW BIOPSY; BRAIN INFARCTION; CASE REPORT; CEREBRAL ARTERY DISEASE; COLD AGGLUTININ SYNDROME; COLON ISCHEMIA; COLON RESECTION; COMPUTER ASSISTED TOMOGRAPHY; COOMBS TEST; CREATININE BLOOD LEVEL; CRYOGLOBULINEMIA; CRYOPRECIPITATE; DEATH; DISEASE COURSE; DRUG DOSE REDUCTION; DRUG WITHDRAWAL; FLOW CYTOMETRY; GENERAL CONDITION DETERIORATION; GIANT CELL ARTERITIS; HAND PARESTHESIA; HEADACHE; HEMAGGLUTINATION; HEMATOPOIESIS; HEMOGLOBIN BLOOD LEVEL; HEMOLYSIS; HUMAN; HUMAN TISSUE; HYPERTENSION; IMMUNOPEROXIDASE STAINING; INTESTINE ISCHEMIA; INTESTINE NECROSIS; KIDNEY DYSFUNCTION; KIDNEY INFARCTION; LACTATE BLOOD LEVEL; LAPAROTOMY; LIVEDO RETICULARIS; LIVER ISCHEMIA; MALE; MESENTERIC BLOOD VESSEL OCCLUSION; MICROVASCULATURE; NAUSEA AND VOMITING; NUCLEAR MAGNETIC RESONANCE IMAGING; PARESTHESIA; PLASMAPHERESIS; PRIORITY JOURNAL; PROTEIN ELECTROPHORESIS; SLURRED SPEECH; SMALL INTESTINE RESECTION; SPLEEN INFARCTION; THIGH; TRANSIENT ISCHEMIC ATTACK; TREATMENT RESPONSE; VISUAL IMPAIRMENT;

ANEMIA, HEMOLYTIC, AUTOIMMUNE; ANTIBODIES, MONOCLONAL; ANTIBODY SPECIFICITY; AUTOANTIBODIES; BLOOD GROUP ANTIGENS; CEREBRAL INFARCTION; COMBINED MODALITY THERAPY; CRYOGLOBULINS; FATAL OUTCOME; GIANT CELL ARTERITIS; HUMANS; IMMUNOGLOBULIN M; IMMUNOSUPPRESSIVE AGENTS; INFARCTION; INTESTINES; ISCHEMIA; KIDNEY; LIVER; MALE; MIDDLE AGED; MULTIPLE ORGAN FAILURE; PLASMAPHERESIS; SPLANCHNIC CIRCULATION; SPLEEN;

EID: 59949084244     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.21330     Document Type: Article

References (24)

1. Gertz MA. Cold agglutinin disease and cryoglobulinemia. Clin Lymphoma 2005; 5:290-293.
2. Berentsen S, Beiske K, Tjonnfjord GE. Primary chronic cold agglutinin disease: An update on pathogenesis, clinical features and therapy. Hematology 2007; 12:361-370.
3. Ferri C, Zignego AL, Pileri SA. Cryoglobulins. J Clin Pathol 2002; 55:4-13.
4. Brouet JC, Clauvel JP, Danon F, et al. Biologic and clinical significance of cryoglobulins. A report of 86 cases. Am J Med 1974; 57:775-788.
5. Montagnino G. Reappraisal of the clinical expression of mixed cryoglobulinemia. Springer Semin Immunopathol 1988; 10:1-19.
6. Dammacco F, Sansonno D, Piccoli C, et al. The cryoglobulins: An overview. Eur J Clin Invest 2001; 31:628-638.
7. Meltzer M, Franklin EC, Elias K, et al. Cryoglobulinemia-A clinical and laboratory study. II. Cryoglobulins with rheumatoid factor activity. Am J Med 1966; 40:837-856.
8. Casato M, Saadoun D, Marchetti A, et al. Central nervous system involvement in hepatitis C virus cryoglobulinemia vasculitis: A multicenter case-control study using magnetic resonance imaging and neuropsychological tests. J Rheumatol 2005; 32:484-488.
9. Petty GW, Duffy J, Houston J III. Cerebral ischemia in patients with hepatitis C virus infection and mixed cryoglobulinemia. Mayo Clin Proc 1996; 71:671-678.
10. Zaja F, De Vita S, Mazzaro C, et al. Efficacy and safety of rituximab in type II mixed cryoglobulinemia. Blood 2003; 101:3827-3834.
11. Gertz MA. Cold hemolytic syndrome. Hematol Am Soc Hematol Educ Program 2006; 19-23.
12. Zilow G, Kirschfink M, Roelcke D. Red cell destruction in cold agglutinin disease. Infusionsther Transfusionsmed 1994; 21:410-415.
13. Packman CH. Hemolytic anemia resulting from immune injury. Chapter 52. 7th Edition. Williams Hematology. In: Marshall A, Lichtman EB, Thomas JK, et al., editors. The McGraw-Hill Medical Publishing Division, New York; 2006. On-line publication.
14. Nydegger UE, Kazatchkine MD, Miescher PA. Immunopathologic and clinical features of hemolytic anemia due to cold agglutinins. Semin Hematol 1991; 28:66-77.
15. Ciejka JZ, Cook EB, Lawler D, et al. Severe cold agglutinin disease and cryoglobulinemia secondary to a monoclonal anti-Pr2 IgM lambda cryoagglutinin. Clin Exp Rheumatol 1999; 17:227-231.
16. Rose VL, Kwaan HC. Anti-Pr cold hemagglutination associated with livedo reticularis. Am J Hematol 1985; 19:419-421.
17. Berentsen S, Ulvestad E, Langholm R, et al. Primary chronic cold agglutinin disease: A population based clinical study of 86 patients. Haematologica 2006; 91:460-466.
18. Hillen HF, Bakker SJ. Failure of interferon-alpha-2b therapy in chronic cold agglutinin disease. Eur J Haematol 1994; 53:242-243.
19. O'Connor BM, Clifford JS, Lawrence WD, et al. Alpha-interferon for severe cold agglutinin disease. Ann Intern Med 1989; 111:255-256.
20. Berentsen S, Tjonnfjord GE, Brudevold R, et al. Favourable response to therapy with the anti-CD20 monoclonal antibody rituximab in primary chronic cold agglutinin disease. Br J Haematol 2001; 115:79-83.
21. Berentsen S, Ulvestad E, Gjertsen BT, et al. Rituximab for primary chronic cold agglutinin disease: A prospective study of 37 courses of therapy in 27 patients. Blood 2004; 103:2925-2928.
22. Lee EJ, Kueck B. Rituxan in the treatment of cold agglutinin disease. Blood 1998; 92:3490-3491.
23. Kuenn JW, Weber R, Teague PO, et al. Cryopathic gangrene with an IgM lambda cryoprecipitating cold agglutinin. Cancer 1978; 42:1826-1833.
24. Buonanno G, Castaldo C, Nitrato IG. Cold agglutinin disease and cryoglobulinemia. Report of two cases. Haematologica 1985; 70:174-177.